InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,170.80
(
-0.19%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.78
(
0.90%
)
Bitcoin
61,394.95
(
-2.79%
)
Post# of 252311
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

cooldrinkh2o

Send PM Follow Ignore
Followers 0
Posts 113
Boards Moderated 0
Alias Born 05/28/2005

cooldrinkh2o

Re: DewDiligence post# 164205

Wednesday, 07/17/2013 5:27:43 PM

Wednesday, July 17, 2013 5:27:43 PM

Post# of 252311
My guess is transplant sales growth is relatively flat. Certican in some EU countries is being used in oncology indications due the large price difference (10 1 mg Certican tablets cost is much lower than 1 10mg Afinitor tablet in all/most EU countries). I would still submit that most of the growth in sales is due to the ER+ BC launch.



Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up